| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 |
| filingDate |
2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_965f7b73a764e5a91ef75cb1edd01cdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_431ed6f234e802dca5d57fa675838075 |
| publicationDate |
2003-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003013688-A1 |
| titleOfInvention |
Synergistic combination of pravastatin and aspirin and method |
| abstract |
A synergistic combination of pravastatin and aspirin is provided which is formed of 40 mg pravastatin and 81 mg or higher of aspirin, preferably 81 mg aspirin or 325 mg of aspirin. A method for preventing, inhibiting or reducing risk of onset of cardiovascular events or cerebrovascular events employing such synergistic combination is also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004108056-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006177435-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004080488-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004080488-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9075050-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8129123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004108056-A3 |
| priorityDate |
2001-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |